Overview This page contains the latest trade data of Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues. In 2023, Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues were the world's 3337th most traded product, with a total trade of $344M. Between 2022 and 2023 the exports of Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues grew by 11%, from $310M to $344M. Trade in Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues represent 0.0015% of total world trade.
Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues are a part of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and....
Exports In 2023 the top exporters of Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues were Czechia ($68.1M), United States ($62.7M), South Korea ($48.6M), Hungary ($41.9M), and Chinese Taipei ($30.7M).
Imports In 2023 the top importers of Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues were Germany ($43.4M), Japan ($40.7M), Austria ($33.6M), Italy ($30.5M), and France ($30M).
Ranking Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues ranks 15th in the Product Complexity Index (PCI).